Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Ferroglobe PLC is set to release its financial results for the second quarter of 2026 on August 4, followed by a conference call on August 5. The company is a global producer of silicon metal and specialty alloys serving sectors such as solar, electronics, automotive, construction, and energy.
Verrica Pharmaceuticals Inc., a US-based dermatological therapeutics company, announced an exclusive distribution, marketing, and supply agreement with Medomie Pharma Ltd. for the commercialization of YCANTH®, a prescription treatment for molluscum contagiosum, in Israel. Under the agreement, Medomie will seek regulatory approvals and distribute th…
Rezolve Ai announced a strategic partnership with Zilch, a UK fintech unicorn, to embed Rezolve Ai's agentic commerce infrastructure into Zilch's payment platform via the Reward platform. This integration aims to provide personalized retailer engagement for nearly 6 million customers, enhance consumer value from everyday spending, and drive signifi…
ASP Isotopes Inc.'s subsidiary Quantum Leap Energy has entered a research agreement with Texas A&M Engineering Experiment Station to advance and de-risk the commercial production of high-purity uranium hexafluoride (UF6), critical to the nuclear fuel enrichment process. This collaboration aims to improve production efficiency, reduce costs, and sup…
Magnite announced that Business Insider has selected its SpringServe video platform to power ad serving and programmatic monetization of its new standalone FAST connected TV (CTV) channel. This move extends Business Insider’s premium video content to third-party platforms, aiming to deepen audience and advertiser engagement within the streaming eco…
Rhythm Pharmaceuticals, a commercial-stage biopharmaceutical company specializing in treatments for rare neuroendocrine diseases, announced it will report its Q2 2026 financial results and host a conference call on August 4, 2026. The company’s lead drug, IMCIVREE (setmelanotide), is FDA-approved for treatment of obesity related to specific genetic…
Enphase Energy announced a new upgrade for European homeowners with existing second-generation IQ Battery systems, allowing them to add backup power and expand their storage capacity using new Enphase products without replacing current batteries. This upgrade enhances energy independence, supports increasing household electricity demands such as EV…
Black Rock Coffee Bar, a leading US drive-thru coffee retailer, announced its plan to host a conference call on August 11, 2026, to discuss the financial results for the second quarter of 2026. The company operates over 200 locations across seven states and is noted for its rapid growth and premium coffee offerings.
VYNE Therapeutics announced a 1-for-50 reverse stock split in connection with its proposed merger with Yarrow Bioscience, expected to close around July 24, 2026. Post-merger, the combined company will trade under the ticker YARW on Nasdaq. VYNE also provided an update on a special cash dividend of $17.3 million payable to stockholders before the re…
Smith+Nephew has introduced ASC Solutions, an expanded enterprise strategy focused on ambulatory surgery centers (ASCs) to support cost optimization, quality, and outcome performance. The initiative includes the ASC ONE delivery model, integrating a network of partners to streamline ASC development and operations, providing a unified customer exper…
CISO Global, Inc. announced the expansion and automation of its TiGRIS governance, risk, and compliance (GRC) platform, which is FedRAMP-certified and designed for complex regulatory environments. The company plans to integrate generative AI capabilities to improve compliance intelligence and risk visibility. This development marks a key step in CI…
Senseonics Holdings, Inc., a medical technology company specializing in implantable continuous glucose monitoring systems, announced it will release its second quarter 2026 financial results after market close on August 6, 2026, followed by a conference call to discuss its performance.
Kratos Defense & Security Solutions has secured an approximate $156 million single-award contract from the U.S. Department of Energy's National Nuclear Security Administration Office of Secure Transportation. The contract supports Project Solar Shield, under which Kratos will deliver mobile Counter-Unmanned Aircraft System (C-UAS) platforms aimed a…
HII announced the appointment of Michael DeBernardis as Vice President and Chief Counsel for its Mission Technologies division. DeBernardis brings nearly 20 years of legal experience advising corporations and government contractors, and will support the division's growth in defense, intelligence, cyber, and related mission areas.
Calidi Biotherapeutics announced positive pre-IND feedback from the FDA on its lead candidate CLD-401, supporting its planned phase I trial targeting metastatic cancers. The company showcased new data expanding its RedTail platform capabilities with in situ T-cell engagers. Cost reductions and strengthened leadership underline progress as Calidi ta…
Westlake Corporation, a global manufacturer of materials and innovative products, will release its second quarter 2026 earnings before market open on August 4, 2026, followed by a conference call to discuss the results. The company provides vital materials across housing, construction, packaging, healthcare, automotive, and consumer goods sectors.
Westlake Chemical Partners announced that it will release its second quarter 2026 earnings on August 4, 2026, before market opening, followed by a conference call to discuss the results. The partnership operates ethylene production facilities and related assets, providing investors with updates on its financial performance.
Rein Therapeutics announced that its Phase 2 RENEW trial evaluating inhaled LTI-03 for idiopathic pulmonary fibrosis is now enrolling across all five planned countries, including the addition of Germany, a key center for pulmonary fibrosis research. The company remains on track to report initial topline data in the second half of 2026. LTI-03 is a …
Exyn Defense, the defense division of Exyn Technologies, announced the start of the Green UAS certification process for its Nexys modular autonomous mapping platform. This certification aligns Nexys with key U.S. government procurement standards, positioning the platform for broader adoption across Department of Defense, federal agencies, and publi…
One Stop Systems, a Nasdaq-listed company specializing in rugged AI and edge computing solutions, announced it has received an initial $2.2 million production order from a manufacturer of autonomous construction and mining equipment following successful prototype testing. Deliveries will span from Q3 2026 through Q3 2027, with anticipated cumulativ…
Oxford Lane Capital Corp., a closed-end investment company focused on collateralized loan obligation vehicles, announced that it will release its first fiscal quarter earnings on July 28, 2026, accompanied by a conference call for investors and analysts.
Abundia Global Impact Group, a low-carbon energy company specializing in converting waste into fuels, has appointed Keith Berger as Chief Commercial Officer. With over 25 years of experience in energy and technology sectors, Berger will lead the company's commercialization strategy, focusing on scaling its waste-to-fuels and renewable chemicals bus…
Arteris, Inc., a semiconductor technology company focusing on AI-related innovations, will announce its second quarter 2026 financial results on August 6, 2026, followed by a management conference call. The company provides network-on-chip IP and SoC software solutions aimed at improving performance and engineering productivity in semiconductor des…
Helus Pharma has completed enrollment ahead of schedule in its pivotal Phase 3 APPROACH study evaluating HLP003 as an adjunctive treatment for major depressive disorder (MDD). The completion marks a significant milestone for the company, with topline data expected in Q4 2026. HLP003 has received FDA Breakthrough Therapy Designation and showed promi…
Canadian Solar (CSIQ) trades at $15.42 after a heavy short bias and regulatory chatter around its U.S. expansion. The company has clear secular opportunities in solar modules and energy storage, and recent operational wins in BESS sales offset module softness. With market cap of roughly $1.03B, PB 0.35 and persistent negative earnings, this is a hi…
